Literature DB >> 10221874

Bacterial toxins: friends or foes?

C K Schmitt1, K C Meysick, A D O'Brien.   

Abstract

Many emerging and reemerging bacterial pathogens synthesize toxins that serve as primary virulence factors. We highlight seven bacterial toxins produced by well-established or newly emergent pathogenic microbes. These toxins, which affect eukaryotic cells by a variety of means, include Staphylococcus aureus alpha-toxin, Shiga toxin, cytotoxic necrotizing factor type 1, Escherichia coli heat-stable toxin, botulinum and tetanus neurotoxins, and S. aureus toxic-shock syndrome toxin. For each, we discuss the information available on its synthesis and structure, mode of action, and contribution to virulence. We also review the role certain toxins have played in unraveling signal pathways in eukaryotic cells and summarize the beneficial uses of toxins and toxoids. Our intent is to illustrate the importance of the analysis of bacterial toxins to both basic and applied sciences.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10221874      PMCID: PMC2640701          DOI: 10.3201/eid0502.990206

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


  34 in total

1.  Shiga toxin, Shiga-like toxin II variant, and ricin are all single-site RNA N-glycosidases of 28 S RNA when microinjected into Xenopus oocytes.

Authors:  S K Saxena; A D O'Brien; E J Ackerman
Journal:  J Biol Chem       Date:  1989-01-05       Impact factor: 5.157

Review 2.  The pathogenic mechanisms of Shiga toxin and the Shiga-like toxins.

Authors:  V L Tesh; A D O'Brien
Journal:  Mol Microbiol       Date:  1991-08       Impact factor: 3.501

3.  Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins.

Authors:  Y Endo; K Tsurugi; T Yutsudo; Y Takeda; T Ogasawara; K Igarashi
Journal:  Eur J Biochem       Date:  1988-01-15

4.  Isolation and nucleotide sequence of the gene encoding cytotoxic necrotizing factor 1 of Escherichia coli.

Authors:  V Falbo; T Pace; L Picci; E Pizzi; A Caprioli
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

Review 5.  Cholera toxin and cholera B subunit as oral-mucosal adjuvant and antigen vector systems.

Authors:  J Holmgren; N Lycke; C Czerkinsky
Journal:  Vaccine       Date:  1993-09       Impact factor: 3.641

6.  Isolation of E. coli O157:H7 from sporadic cases of hemorrhagic colitis - United States.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1982-11-05       Impact factor: 17.586

Review 7.  Targeting new thrombolytic regimens at specific patient groups: implications for research and cost-containment.

Authors:  A Maseri; F Andreotti
Journal:  Eur Heart J       Date:  1997-12       Impact factor: 29.983

8.  Evidence for two types of cytotoxic necrotizing factor in human and animal clinical isolates of Escherichia coli.

Authors:  J De Rycke; E A González; J Blanco; E Oswald; M Blanco; R Boivin
Journal:  J Clin Microbiol       Date:  1990-04       Impact factor: 5.948

Review 9.  Alpha-toxin of Staphylococcus aureus.

Authors:  S Bhakdi; J Tranum-Jensen
Journal:  Microbiol Rev       Date:  1991-12

10.  Crystal structure of the cell-binding B oligomer of verotoxin-1 from E. coli.

Authors:  P E Stein; A Boodhoo; G J Tyrrell; J L Brunton; R J Read
Journal:  Nature       Date:  1992-02-20       Impact factor: 49.962

View more
  30 in total

1.  Purification and characterization of a UDP-glucosyltransferase produced by Legionella pneumophila.

Authors:  Iouri Belyi; Michel R Popoff; Nicholas P Cianciotto
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

2.  Regulation of Apoptosis by Gram-Positive Bacteria: Mechanistic Diversity and Consequences for Immunity.

Authors:  Glen C Ulett; Elisabeth E Adderson
Journal:  Curr Immunol Rev       Date:  2006-05

Review 3.  The biology and future prospects of antivirulence therapies.

Authors:  Lynette Cegelski; Garland R Marshall; Gary R Eldridge; Scott J Hultgren
Journal:  Nat Rev Microbiol       Date:  2008-01       Impact factor: 60.633

Review 4.  Emerging nanotechnology-based strategies for the identification of microbial pathogenesis.

Authors:  Charalambos Kaittanis; Santimukul Santra; J Manuel Perez
Journal:  Adv Drug Deliv Rev       Date:  2009-11-13       Impact factor: 15.470

Review 5.  Targeting virulence not viability in the search for future antibacterials.

Authors:  Begoña Heras; Martin J Scanlon; Jennifer L Martin
Journal:  Br J Clin Pharmacol       Date:  2015-02       Impact factor: 4.335

Review 6.  Emerging insights into the biology of typhoid toxin.

Authors:  Casey C Fowler; Shu-Jung Chang; Xiang Gao; Tobias Geiger; Gabrielle Stack; Jorge E Galán
Journal:  Curr Opin Microbiol       Date:  2017-02-16       Impact factor: 7.934

7.  A mechanism of cell death involving an adenylyl cyclase/PKA signaling pathway is induced by the Cry1Ab toxin of Bacillus thuringiensis.

Authors:  Xuebin Zhang; Mehmet Candas; Natalya B Griko; Ronald Taussig; Lee A Bulla
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-20       Impact factor: 11.205

8.  Interfacial folding and membrane insertion of designed peptides studied by molecular dynamics simulations.

Authors:  Wonpil Im; Charles L Brooks
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-28       Impact factor: 11.205

Review 9.  Pathogenicity islands in bacterial pathogenesis.

Authors:  Herbert Schmidt; Michael Hensel
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

10.  Characterization of an actin-targeting ADP-ribosyltransferase from Aeromonas hydrophila.

Authors:  Adin Shniffer; Danielle D Visschedyk; Ravikiran Ravulapalli; Giovanni Suarez; Zachari J Turgeon; Anthony A Petrie; Ashok K Chopra; A Rod Merrill
Journal:  J Biol Chem       Date:  2012-09-11       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.